与真菌相关的内型是支气管切除症中可治疗的特征
Kai Xian Thng1,2, Micheál Mac Aogáin3,4, Sanjay H Chotirmall5,6
1Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, Singapore, 308232, Singapore.
Pulmonary therapy
|December 30, 2025
概括
菌在支气管切除症中起着重要作用,影响疾病的严重程度和炎症. 先进的分子技术正在改善诊断和理解这种情况的真菌感染.
科学领域:
- 肺部病理学 肺部病理学
- 菌类学 菌类学是指菌类学.
- 微生物组研究 微生物组研究
背景情况:
- 支气管切除症的特点是结构异常和粘膜清除受损,从而产生对真菌殖民的倾向.
- 支气管病的真菌殖民越来越多地与疾病的严重程度,恶化频率和呼吸道炎症有关.
- 宿主免疫力显著影响 bronchiectasis 菌的免疫病原性反应.
研究的目的:
- 审查菌在支气管病变中的临床意义.
- 讨论目前诊断和治疗支气管炎的真菌感染的挑战.
- 探索新兴的真菌相关的内型和环境因素的影响.
主要方法:
- 在支气管切除病理生理学中对真菌的新兴证据的审查.
- 对诊断局限性的分析以及培养独立分子技术的前景.
- 整合下一代测序和微生物组学数据.
主要成果:
- 与真菌相关的特征与支气管切除症的严重程度,恶化和炎症相关.
- 下一代测序识别了难以培养的真菌,进步了对微生物群的理解.
- 综合性微生物组学揭示了真菌与细菌 (例如,Pseudomonas aeruginosa) 以及远处器官中的作用.
- 与真菌相关的炎症内型代表了潜在的可治疗的特征.
- 空气污染和气候变化等环境因素会影响与真菌相关的支气管病变的内型.
结论:
- 菌是支气管炎症的关键参与者,影响疾病的进展和炎症.
- 改进的诊断,特别是分子方法,对于管理真菌参与至关重要.
- 了解由暴露体影响的真菌相关的内型,是针对性治疗的关键.
相关概念视频
01:28Fungal Phylum Microsporidia
367
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
367
01:23Cystic Fibrosis: Pathogenesis
674
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
674
01:24Cystic Fibrosis: Management
434
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
434
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K